In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.
In a nationwide observational study published this month in The Journal of the American Medical Association (JAMA), cardiologists from the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) were commissioned by the U.S. Food and Drug Administration (FDA) to examine trends in the use and long-term safety of a device widely used to treat pulmonary embolism, or blood clots in the lungs.
OpenNotes, an international leader in health transparency research at Beth Israel Deaconess Medical Center (BIDMC), and Abridge, a leading generative AI platform for clinical documentation, launched a partnership that will bring patient-clinician conversations to the forefront of research to enhance patient notes.
Cardiovascular disease (CVD) is the primary cause of death among adults over age 65 years. Seniors are also likely to have low blood levels of Vitamin D, which has been linked to cardiovascular disease. Despite this, many observational trials have not demonstrated that Vitamin D supplementation reduces cardiovascular disease risk.
A study led by Adam Rodman, MD, MPH, Director of AI Programs at Beth Israel Deaconess Medical Center (BIDMC), reveals that, rather than helping to reduce racial and ethnic biases, AI-driven chatbots may instead perpetuate and exacerbate disparities in medicine.
Research shows people previously vaccinated against mpox in 2022 had declining antibody responses after six to 12 months, as World Health Organization (WHO) designates the 2024 mpox outbreak a public health emergency of international concern.
In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson’s disease was 76 percent higher among those with a history of damage to the lining of their upper gastrointestinal (GI) tract than among those without.
Rohit N. Kulkarni, MD, PhD, the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at Joslin Diabetes Center, has been awarded $9,920,607 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Investigators used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles to provide novel critical molecular insights into Alzheimer’s Disease (AD) that single-omic analyses cannot offer.
Beth Israel Lahey Health has expanded its cardiovascular services to include heart transplantation based at Beth Israel Deaconess Medical Center.
Two studies are included: Total joint replacement outcomes in the unhoused and health literacy linked to shoulder arthroplasty outcomes
In this study, researchers at Beth Israel Deaconess Medical Center found that Black adults underwent significantly more endovascular peripheral vascular interventions (PVI), were treated for more advanced disease and were also more likely to experience adverse outcomes following PVI procedures, including amputation and death.  
Researchers at Beth Israel Deaconess Medical Center conducted a comprehensive investigation of national trends in cardiovascular mortality among Black and white women and men across multiple socio-demographic domains and found a decline in cardiovascular mortality rates across all groups over the last 20 years.
Researchers report that exposure to cold temperatures resolved obesity-induced inflammation while improving insulin sensitivity and glucose tolerance in diet-induced obese mice.
In a new paper published in JAMA, researchers evaluated mental health and substance use among homeless and housed high school students surveyed voluntarily and anonymously in 2019.
Lahey Hospital & Medical Center (LHMC) today announced the opening of its new Hypertrophic Cardiomyopathy (HCM) medical and surgical center.
Scientists have demonstrated in mice that the benefits of exercise may also span generations.
Scientists sought to determine whether high blood glucose blunts the body’s response to exercise and whether lowering it can restore the ability to improve aerobic capacity with training.
Joslin Diabetes Center, the preeminent institution for diabetes research and care, affiliated with Harvard Medical School and a part of Beth Israel Lahey Health, has again been awarded $8.5 million from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) in continued support for Joslin’s Diabetes Research Center (DRC) program. The grant, which officially began April 1, 2022, marks the 36th continuous year of NIH investment in Joslin’s DRC.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right